Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
332.50    0.50 (0.15%)
Bid:
331.50
Ask:
332.50
Spread: 1.00 (0.302%)
Market Cap: £766.97m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

19 May 2016 07:00

RNS Number : 6675Y
Chesnara PLC
19 May 2016
 

Chesnara plc Directorate Change

For 7am release on 19 May 2016

 

New Non Executive Director

 

Chesnara plc

("Chesnara" or "the Company")

Appointment of Jane Dale as non-executive Director

 

The Board of Chesnara is pleased to announce the appointment of Jane Dale as an independent non-executive director, with effect from 19 May 2016. Upon her appointment Jane will join the Chesnara plc Nomination & Governance Committee and the Audit & Risk Committee. Jane will also be joining the Board of Countrywide Assured plc as a Non-Executive director.

Jane has over 30 years' extensive financial and operational experience in the financial and insurance sector. She has previously held senior finance and managing director roles at AIG Life Limited, Aviva Group, and Legal & General Group plc. Jane has also held the position of independent non-executive director of British Gas Services Limited since 2009 and is currently the Chairman of BHSF Group Ltd.

In addition Eithne McManus will be appointed as non-executive director to the Countrywide Assured plc Board with effect from 19 May 2016. She is a non-executive director of UIA (Insurance) Ltd and a director of Alban Actuarial Solutions. Eithne was previously a director of Countrywide Assured plc and the City of Westminster Assurance Company Limited both of which are part of the Chesnara Group. Joining Eithne on the Board, as Finance Director of Countrywide Assured plc, is Andrew Richards. Andrew is experienced in the life insurance sector and has strong financial and regulatory reporting knowledge. Andrew has been Group Financial Controller at Chesnara since early 2013 and previously worked for Deloitte LLP for over ten years.

The Chairman, Peter Mason, commented:

'I am delighted to be able to announce the appointment of Jane, Eithne and Andrew. They bring extremely valuable experience, knowledge and skills which will be of significant benefit to the Group.'

No other information in connection with Jane Dales appointment is required to be disclosed pursuant to LR 9.6.13R

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAAPMLTMBIBBTF
Date   Source Headline
24th Oct 20227:00 amRNSBlock listing Interim Review
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAppointment of Group GC & Company Secretary
29th Sep 20227:00 amRNSBlock Listing Application
12th Sep 20227:15 amEQSHardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
8th Sep 202212:05 pmEQSHardman Talks Video: Interview Chesnara management discuss 2022 half-year results
2nd Sep 20227:00 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report
23rd Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSNotice of Interim Results
15th Aug 20222:45 pmEQSHardman & Co: Q&A on Chesnara Plc (CSN) Conservatrix acquisition boosts AuA and cash flow with capacity for more
8th Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20227:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSChesnara Enhances M&A and Commercial Capabilities
29th Jul 20227:15 amEQSHardman & Co Research: Chesnara plc (CSN): Another fine acquisition
22nd Jul 20227:00 amRNSAcquisition
16th Jun 20229:15 amEQSHardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
31st May 20227:00 amRNSTotal Voting Rights
24th May 20227:00 amEQSHardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges
17th May 20221:51 pmRNSResult of AGM
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSAcquisition Completions
22nd Apr 20227:00 amRNSBlock listing Interim Review
21st Apr 20227:00 amRNSNotice of AGM
8th Apr 20227:00 amRNSAcquisition Update
5th Apr 20222:30 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSFinal Results
17th Mar 20227:00 amRNSNotice of Results
15th Mar 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSDirectorate Change
2nd Feb 20223:07 pmRNS£200m Inaugural Tier 2 Subordinated Notes Issuance
26th Jan 20227:00 amRNSHolding(s) in Company
17th Jan 20227:00 amRNSDirectorate Change
17th Dec 20217:00 amRNSSenior Leadership Appointment
9th Dec 20217:00 amRNSHolding(s) in Company
2nd Dec 20211:50 pmEQSHardman & Co Research : Chesnara (CSN) Initiation of Coverage: Could be the least worrying dividend you'll get
26th Nov 20211:00 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSAcquisition
22nd Oct 20217:00 amRNSBlock listing Interim Review
19th Oct 20217:00 amRNSDirectorate Change
13th Sep 20217:00 amRNSProposed Acquisition
7th Sep 20217:00 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
12th Aug 20217:00 amRNSNotice of Results
2nd Aug 20217:00 amRNSDirectorate Change
28th May 20214:36 pmRNSHolding(s) in Company
28th May 20217:00 amRNSTotal Voting Rights
21st May 20217:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
18th May 20213:30 pmRNSResult of AGM
12th May 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.